Keyphrases
Cancer Therapy
100%
Anti-BRAF
100%
Anti-MEK
100%
EIF4F
100%
EIF4F Complex
100%
EIF4G1
100%
BRAFV600
100%
Tumor
75%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
75%
Resistance Mechanisms
50%
Drug Combination
50%
Mitogen-activated Protein Kinase
50%
Complex Formation
50%
EIF4A
50%
4E-BP1
50%
Cancer Cells
25%
Drug Target
25%
Therapeutic Target
25%
Synergize
25%
Metastasis
25%
Messenger RNA (mRNA)
25%
B-cell Lymphoma 2 (Bcl-2)
25%
Signal Transduction Pathway
25%
Phosphorylation
25%
RNA Helicase
25%
Scaffold Protein
25%
Pro-apoptotic
25%
Resistance to Treatment
25%
MEK-ERK
25%
Phosphoinositide 3-kinase (PI3K)
25%
Apoptotic Cascade
25%
Acquired Resistance
25%
Resistance to Drugs
25%
5′-end
25%
Melanoma Cells
25%
In Situ Techniques
25%
Dependent Degradation
25%
Caspase-dependent
25%
Colon Cancer Cells
25%
Thyroid Cancer Cell Lines
25%
Innate Resistance
25%
Persistent Formation
25%
Translation Initiation Complex
25%
PI3K-AKT-mTOR Pathway
25%
Modifying Factors
25%
Eukaryotic Translation
25%
MEK Kinase
25%
Cap-binding Protein
25%
Biochemistry, Genetics and Molecular Biology
Mitogen-Activated Protein Kinase
100%
Cancer Cell
100%
Binding Protein
100%
Complex Formation
100%
Colon
50%
Signal Transduction
50%
Mammalian Target of Rapamycin
50%
Drug Targeting
50%
RNA Helicase
50%
Scaffold Protein
50%
Caspase
50%
Translation Initiation
50%
Eukaryotic Translation
50%
Initiation Complex
50%
Messenger RNA
50%
Medicine and Dentistry
Cancer Therapy
100%
Tight Junction
100%
Initiation Factor 4F
100%
Initiation Factor 4G
50%
Initiation Factor 4E
50%
Neoplasm
37%
Mitogen-Activated Protein Kinase
25%
Initiation Factor 4A
25%
Complex Formation
25%
Malignant Neoplasm
12%
Cancer Cell
12%
Metastatic Carcinoma
12%
Combination Drug
12%
Mammalian Target of Rapamycin
12%
Protein Binding
12%
Drug Delivery System
12%
Kinase Signaling
12%
Kinase
12%
Caspase
12%
Signal Transduction Pathway
12%
Initiation Factor 4E Binding Protein 1
12%
Colon Cancer Cell Line
12%
Scaffold Protein
12%
Thyroid Cancer Cell Line
12%
Translation Initiation
12%
Cap Binding Protein
12%
RNA Helicase
12%
Messenger RNA
12%
Melanoma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Initiation Factor 4F
100%
Initiation Factor 4G
50%
Initiation Factor 4E
50%
Neoplasm
37%
Mitogen Activated Protein Kinase
25%
Initiation Factor 4A
25%
Combination Drug
12%
Drug Delivery System
12%
Caspase
12%
Melanoma
12%
Thyroid Cancer
12%
Binding Protein
12%
Colon Carcinoma
12%
RNA Helicase
12%
Scaffold Protein
12%
Initiation Factor 4E Binding Protein 1
12%
Cap Binding Protein
12%
Messenger RNA
12%